Related Experiment Video
Updated: Mar 3, 2026
Fabrication and Optimization of Type II Silicon Clathrate Films
Published on: October 14, 2025
Calcium phosphates and silicon: exploring methods of incorporation
Ana I Rodrigues1,2,3,4, Rui L Reis1,2, Clemens A van Blitterswijk3,4
13B's Research Group - Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark - Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco GMR, Portugal.
This study investigated how adding silicon to calcium phosphate (CaP) coatings affects human mesenchymal stem cells (hMSCs). The researchers used two methods to incorporate silicon: adsorption and coprecipitation. They found that silicon could be successfully added to the coatings and that the cells responded to its presence. As the silicon concentration increased, so did the expression of osteogenic markers in the hMSCs. The study also showed that hMSCs cultured on CaP-I coatings had higher levels of alkaline phosphatase and osteopontin, suggesting this method may be more effective. The results indicate that silicon enhances the osteogenic potential of CaP coatings in a dose-dependent way. The study supports the use of silicon as a bioinorganic additive in bone graft substitutes.
Area of Science:
- Biomaterials in regenerative medicine
- Bone tissue engineering
- Calcium phosphate-based coatings
Background:
Despite advances in bone grafting, large bone defects remain a clinical challenge. Calcium phosphate (CaP) coatings are widely used in bone repair due to their biocompatibility and osteoconductivity. However, their osteoinductive properties are limited, prompting research into bioinorganic additives. Silicon (Si) is known to play a role in bone formation and has been linked to enhanced osteoblast activity. Prior research has shown that Si can promote mesenchymal stem cell (MSC) differentiation into the osteogenic lineage. Yet, the mechanisms by which Si interacts with CaP coatings remain unclear. This gap motivated the current study to explore how Si can be incorporated into CaP coatings. The study aimed to determine whether Si addition could enhance the osteogenic potential of these coatings. The focus was on evaluating the effects of Si incorporation methods on MSC behavior. This research provides new insights into the role of Si in bone tissue engineering.
Purpose Of The Study:
This study aimed to evaluate the effects of silicon incorporation into calcium phosphate (CaP) coatings on human mesenchymal stem cell (hMSC) behavior. The specific problem addressed was the limited osteoinductive capacity of CaP coatings in bone tissue engineering. The motivation was to determine whether silicon could enhance the osteogenic differentiation of hMSCs. The study focused on two methods of Si addition: adsorption and coprecipitation. The goal was to assess how these methods affect the physicochemical properties of the coatings. The researchers also examined the dissolution behavior of the modified coatings. The ultimate objective was to identify the optimal method for Si incorporation to improve osteogenic outcomes. This approach could lead to better-performing bone graft substitutes.
Main Methods:
The study used tissue culture plastic well plates coated with a thin calcium phosphate (CaP) layer. Trace amounts of silicon (Si) were added to the coatings using two methods: adsorption and coprecipitation. The physicochemical and structural properties of the modified coatings were analyzed. The dissolution behavior of the coatings was also evaluated. Human mesenchymal stem cells (hMSCs) were cultured on the coatings to assess cell proliferation and osteogenic differentiation. The expression of osteogenic markers was measured to evaluate the effects of Si. A one-way ANOVA with Bonferroni post-hoc test was used for statistical analysis. The study compared the effects of different Si concentrations on hMSC behavior.
Main Results:
The study found that silicon (Si) could be successfully incorporated into calcium phosphate (CaP) coatings using both adsorption and coprecipitation methods. The Si ions were released from the coatings, indicating successful integration. Human mesenchymal stem cells (hMSCs) cultured on the modified coatings showed increased osteogenic differentiation. The expression of osteogenic markers increased with higher Si concentrations. The results demonstrated a dose-dependent response to Si in the coatings. hMSCs cultured on CaP-I coatings showed higher levels of alkaline phosphatase (ALP) and osteopontin (OP). This suggests that CaP-I may be the preferred method for Si incorporation. The study provides evidence that Si enhances the osteogenic potential of CaP coatings.
Conclusions:
The study concluded that silicon (Si) can be effectively incorporated into calcium phosphate (CaP) coatings using adsorption or coprecipitation. The presence of Si in the coatings influenced the osteogenic differentiation of human mesenchymal stem cells (hMSCs). The results suggest that Si enhances the osteogenic potential of CaP coatings in a dose-dependent manner. The study supports the use of Si as a bioinorganic additive in bone graft substitutes. The researchers observed higher levels of ALP and OP in hMSCs cultured on CaP-I coatings. This indicates that CaP-I may be the more effective method of Si incorporation. The findings align with the hypothesis that Si promotes osteogenic differentiation. The study provides a foundation for further research on bioinorganic additives in bone tissue engineering.
Frequently Asked Questions
The study found that increasing silicon concentration in CaP coatings led to higher expression of osteogenic markers in hMSCs.
Silicon was added to CaP coatings through adsorption and coprecipitation methods.
This statistical method was used to compare the effects of different Si concentrations on hMSC behavior.
Higher levels of ALP and OP in hMSCs suggest enhanced osteogenic differentiation due to Si incorporation.
The study showed a dose-dependent increase in osteogenic marker expression with higher Si concentrations.
The researchers propose that CaP-I may be the preferred method for Si incorporation due to higher ALP and OP levels.
